Description
| Product Name | Details | CAT.No | Size |
| Lipoprotein (a) | Suitable for Hitachi 917 | HIT0130A | R1: 2 x 20ml R2: 1 x 8ml |
| Lipoprotein (a) | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0130B | R1: 2 x 20ml R2: 1 x 8ml |
| Lipoprotein (a) | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF130A | R1: 1 x 10ml R2: 1 x 6ml |
Product Description
The Biorex Diagnostics Lipoprotein (Lp(a)) Assay is a high-quality in vitro diagnostic test designed for the quantitative determination of Lp(a) in human serum and plasma. Lp(a) is a genetically determined lipoprotein that plays a significant role in cardiovascular health and atherosclerotic disease. Elevated levels of Lp(a) are associated with an increased risk of coronary artery disease, stroke, and other cardiovascular events. Accurate measurement of Lp(a) is essential for identifying at-risk individuals, monitoring disease progression, and guiding clinical decision-making.
The use of validated assays provides an objective assessment of laboratory method performance and is an integral part of good laboratory practice. By incorporating the Biorex Lp(a) Assay into routine workflows, laboratories can reliably measure serum and plasma Lp(a) levels, detect genetically predisposed individuals, and support cardiovascular risk assessment. Early identification of elevated Lp(a) allows clinicians to implement appropriate lifestyle interventions, therapeutic strategies, and monitoring plans to reduce long-term cardiovascular risk.
Manufactured under strict quality standards, the Biorex Diagnostics Lp(a) Assay delivers stable, reproducible, and clinically meaningful results. The immunoturbidimetric method ensures high accuracy, sensitivity, and consistency, providing laboratories with reliable performance across multiple testing runs. The assay is fully compatible with automated analyzers, including Hitachi 917, Olympus AU600/400/640, and CA 180/270/400/2700 Furuno/Daytona systems, facilitating seamless integration into high-throughput laboratory workflows and enhancing efficiency.
Key Features
- Quantitative Measurement: Accurate determination of Lp(a) in serum and plasma.
- Clinical Relevance: Supports assessment of cardiovascular risk and atherosclerotic disease.
- High Accuracy and Reproducibility: Immunoturbidimetric method ensures consistent results.
- Genetic Risk Detection: Identifies individuals predisposed to elevated Lp(a) levels.
- Automated Analyzer Compatibility: Optimised for Hitachi, Olympus, and CA Furuno/Daytona systems.
Benefits
The Biorex Diagnostics Lp(a) Assay provides laboratories with a reliable solution for evaluating cardiovascular risk and managing atherosclerotic disease. Its precision, reproducibility, and automated system compatibility make it an essential tool for clinical laboratories, hospital diagnostics, and cardiovascular research, supporting accurate interpretation and improved patient care.
Contact Us for more information.